1 results for Adami, S

  • Denosumab for prevention of fractures in postmenopausal women with osteoporosis

    Cummings, SR; Martin, JS; McClung, MR; Siris, ES; Eastell, R; Reid, Ian; Delmas, PD; Austin, Matthew; Wang, A; Kutilek, S; Adami, S; Zanchetta, J; Libanati, C; Siddhanti, S; Christiansen, C; Zoog, HB (2009)

    Journal article
    The University of Auckland Library

    Denosumab is a fully human monoclonal antibody to the receptor activator of nuclear factor-κB ligand (RANKL) that blocks its binding to RANK, inhibiting the development and activity of osteoclasts, decreasing bone resorption, and increasing bone density. Given its unique actions, denosumab may be useful in the treatment of osteoporosis.

    View record details